Skip to Main Content
Try STAT+ TODAY
Trending:
Coronavirus
Biotech
Health
First Opinion
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
First Opinion
STAT+

‘There are a lot of potential Modernas’: The ‘Massachusetts Miracle’ is alive and well

By Shirley LeungDec. 27, 2020

Reprints
Medical syringe & moderna logo
Jakub Porzycki/NurPhoto via AP

With the Moderna vaccine, Massachusetts is having a moment.

Ours is a story not about one company and one vaccine, but rather of countless doctors and doctorates at dozens of labs and companies that have risen to the occasion to vanquish a virus.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Shirley Leung

Shirley Leung is a Boston Globe columnist.

Tags

Trending
cytokine storm cell signalling
FDA rejects antidepressant seen as possible Covid-19 treatment
FDA rejects antidepressant seen as possible Covid-19 treatment
acute flaccid myelitis micrograph
Puzzling pediatric hepatitis cases echo an earlier mysterious illness
Puzzling pediatric hepatitis cases echo an earlier mysterious illness
Eli Lilly headquarters
FDA approves Lilly diabetes drug that analysts expect to…
FDA approves Lilly diabetes drug that analysts expect to be a big seller
Recommended
Pills dollar QALY
Two dozen states side with HHS in its raucous…
Two dozen states side with HHS in its raucous dispute with pharma over a drug discount…
Bakul Patel
Google taps FDA’s former digital health chief for global…
Google taps FDA’s former digital health chief for global strategy role
cytokine storm cell signalling
FDA rejects antidepressant seen as possible Covid-19 treatment
FDA rejects antidepressant seen as possible Covid-19 treatment

Recommended Stories

Benjamins
Biotech

Apollo acquires minority stake in Sofinnova, extending private equity dealmaking in life sciences

By Allison DeAngelis

Exclusive

Senate FDA legislation will include dietary supplement, cosmetic reforms

By Nicholas Florko

Biotech

Police reports detailing Seagen CEO’s arrest raise questions about biotech’s response

By Damian Garde

Roche HQ
Biotech

Roche anti-TIGIT cancer immunotherapy fails second clinical trial, raising doubts about drug class

By Adam Feuerstein

Biotech

A new biotech investment firm, headed by a pair of noteworthy VCs, seeks to ‘free the founders’

By Allison DeAngelis